FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers

October 8, 2024

FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers

In October 2024, the U.S. Food and Drug Administration issued a final guidance titled Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers. https://www.fda.gov/media/166215/download  

 
This guidance provides recommendations on the use of electronic systems, electronic records and electronic signatures in food, medical product, tobacco product, and new animal drug clinical investigations. 

This guidance finalizes the draft guidance for industry issued in March 2023, titled Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11–Questions and Answers.  

Flex Databases has analyzed the guidance and is ready to share how we support our Clients being the trusted software development vendor. 

Regulated entities are responsible for ensuring that electronic records meet applicable part 11 requirements. When determining the suitability of the IT service and IT service provider, regulated entities should consider the following regarding the IT service provider’s ability to ensure the authenticity, integrity, and confidentiality of clinical investigation records and data:  

FDA requirement Flex Databases guarantees 
Processes and procedures the IT service provider has in place for validation of specific IT services to be used in the clinical investigation  Fully validated system with the validation deliverables package Support during User Acceptance Testing 
Ability of the IT service provider to generate accurate and complete copies of records and to provide access to data for as long as the records are required to be retained by applicable regulations  Retention period is negotiated and captured in the contract. All the data stored in the system is subject to full backup and is stored as long as required. 
Processes and procedures the IT service provider has for data migration, data backup, recovery, contingency plans, and retaining records and making them available for FDA inspection for as long as the records are required to be retained by applicable regulations Always ready to share our SOPs, including the backup procedure, Disaster Recovery and Business Continuity Plans and Reports, data migration working practice and relevant deliverables  
Ability to provide secure, computer-generated, time-stamped audit trails of users’ actions and changes to data Audit trail captures all actions performed in the system 
Ability to secure and protect the confidentiality of data at rest and in transit (as appropriate for the content and nature of the record) All traffic into and out of the Flex Databases Platform is encrypted, all backups are encrypted-in-transit to the separate data center and are encrypted-at-rest while stored at that location. 

Blog

May 22, 2025
Product Updates: Smarter Planning, Cleaner Data, and Seamless Integration Across Modules

We’re excited to share the latest enhancements across multiple Flex Databases modules, all designed to improve your efficiency, reduce duplication, and support better data consistency throughout your clinical operations. CRA Activity Management: SDV Log Tracker To improve source data verification (SDV) oversight, we’ve introduced a new SDV Log Tracker. This tracker pulls data from Subject […]

May 20, 2025
Clinical trial memes

Clinical research is serious – but a little humor goes a long way. To celebrate International Clinical Trials Day, we’ve created a few memes that only researchers will truly appreciate. Because sometimes, laughter is the best medicine (after rigorous testing, of course).

May 15, 2025
How to Choose the Right eTMF Model

An electronic Trial Master File plays a central role in maintaining oversight, ensuring regulatory compliance, and supporting successful inspections by health authorities. An efficient eTMF is no longer optional – it’s essential. Choosing the right eTMF model for your clinical studies directly impacts how effectively your teams can manage documentation, maintain version control, and collaborate […]

May 14, 2025
Flex Databases Product Updates – April

Smarter, Safer, and More Automated – Feature Enhancements Across Project Catalogue, CRA Activity Management, Pharmacovigilance, ST&I, and API. Project Catalogue: Smarter Subject Tracking with Randomization Logic We’ve added a new toggle to project settings: “Randomization of the Project”. You can now define whether a project is Randomized or Non-Randomized, helping the system adapt how it […]

Contact us

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.